1. Home
  2. DYN vs DFH Comparison

DYN vs DFH Comparison

Compare DYN & DFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • DFH
  • Stock Information
  • Founded
  • DYN 1984
  • DFH 2008
  • Country
  • DYN United States
  • DFH United States
  • Employees
  • DYN N/A
  • DFH N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • DFH Homebuilding
  • Sector
  • DYN Health Care
  • DFH Consumer Discretionary
  • Exchange
  • DYN Nasdaq
  • DFH Nasdaq
  • Market Cap
  • DYN 2.6B
  • DFH 3.1B
  • IPO Year
  • DYN 2020
  • DFH 2021
  • Fundamental
  • Price
  • DYN $25.95
  • DFH $27.17
  • Analyst Decision
  • DYN Strong Buy
  • DFH Hold
  • Analyst Count
  • DYN 11
  • DFH 1
  • Target Price
  • DYN $51.18
  • DFH $38.00
  • AVG Volume (30 Days)
  • DYN 836.3K
  • DFH 885.6K
  • Earning Date
  • DYN 11-12-2024
  • DFH 10-31-2024
  • Dividend Yield
  • DYN N/A
  • DFH N/A
  • EPS Growth
  • DYN N/A
  • DFH 15.80
  • EPS
  • DYN N/A
  • DFH 3.03
  • Revenue
  • DYN N/A
  • DFH $4,028,851,000.00
  • Revenue This Year
  • DYN N/A
  • DFH $15.83
  • Revenue Next Year
  • DYN N/A
  • DFH N/A
  • P/E Ratio
  • DYN N/A
  • DFH $8.94
  • Revenue Growth
  • DYN N/A
  • DFH 8.59
  • 52 Week Low
  • DYN $11.66
  • DFH $23.46
  • 52 Week High
  • DYN $47.45
  • DFH $44.38
  • Technical
  • Relative Strength Index (RSI)
  • DYN 38.55
  • DFH 32.01
  • Support Level
  • DYN $25.27
  • DFH $26.89
  • Resistance Level
  • DYN $28.96
  • DFH $30.71
  • Average True Range (ATR)
  • DYN 1.41
  • DFH 1.17
  • MACD
  • DYN -0.23
  • DFH -0.47
  • Stochastic Oscillator
  • DYN 14.25
  • DFH 3.45

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

About DFH Dream Finders Homes Inc.

Dream Finders Homes Inc is engaged in the home building business. It designs, builds, and sells homes in Jacksonville, Orlando, Denver, the Washington D.C. metropolitan area, and Austin. The company operates through six geographical divisions namely, Jacksonville, Orlando, Denver, Washington DC (Capital), and the Carolinas (H&H Homes), Jet Home Loans LLC. Jacksonville division generates majority of the revenue for the firm.

Share on Social Networks: